期刊
DISEASE MODELS & MECHANISMS
卷 8, 期 5, 页码 421-427出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.017236
关键词
AMD; RPE; Cell-culture models; hESC; iPSC; Stem-cell therapy
资金
- Beckman Initiative for Macular Research
- Garland Initiative for Vision
- Wynn-Gund Translational Research Acceleration Program of the Foundation Fighting Blindness
- UCSB Institute for Collaborative Biotechnologies through grant from U.S. Army Research Office [W911NF-09-0001]
- California Institute for Regenerative Medicine [DR1-01444, CL1-00521, FA1-00616]
Age-related macular degeneration (AMD) is a complex neurodegenerative visual disorder that causes profound physical and psychosocial effects. Visual impairment in AMD is caused by the loss of retinal pigmented epithelium (RPE) cells and the light-sensitive photoreceptor cells that they support. There is currently no effective treatment for the most common form of this disease (dry AMD). A new approach to treating AMD involves the transplantation of RPE cells derived from either human embryonic or induced pluripotent stem cells. Multiple clinical trials are being initiated using a variety of cell therapies. Although many animal models are available for AMD research, most do not recapitulate all aspects of the disease, hampering progress. However, the use of cultured RPE cells in AMD research is well established and, indeed, some of the more recently described RPE-based models show promise for investigating the molecular mechanisms of AMD and for screening drug candidates. Here, we discuss innovative cell-culture models of AMD and emerging stem-cell-based therapies for the treatment of this vision-robbing disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据